title: MAM: a "new" high-incidence antigen found on multiple cell lines.
abstract: BACKGROUND
  Three women have been identified with an antibody to a "new" high-incidence antigen found on multiple cell lines.
  
  
  METHODS
  The proposita, M.A.M., presented during her third pregnancy with an antibody reacting with all RBCs tested except her own. She delivered a thrombocytopenic infant with a 3+ DAT, but without symptoms of HDN. The second example, A.N., presented during her third pregnancy with an antibody reacting with all RBCs tested except her own and those of M.A.M. She delivered a slightly thrombocytopenic but severely anemic infant. The third example, F.K., a sister of A.N., has an antibody reacting with all RBCs tested except her own and those of M.A.M. and A.N.
  
  
  CONCLUSIONS
  This "new" high-incidence antigen has been named MAM and assigned high-incidence antigen number 901016 by the International Society of Blood Transfusion. The corresponding antibody, anti-MAM, has been shown to cause HDN and has the potential to shorten RBC survival after the transfusion of incompatible RBC units, as determined by monocyte monolayer assay. Immunoblotting and flow cytometry show that this new antibody reacts with various WBC lines in addition to RBCs. This antibody also appears to react with platelets in some assays.
authors.affiliation: National Reference Laboratory for Blood Group Serology, American Red Cross, Philadelphia, Pennsylvania, USA. wmontgomery@immucor.com
authors.forename: W M
authors.initials: WM
authors.lastname: Montgomery
authors.forename: S J
authors.initials: SJ
authors.lastname: Nance
authors.forename: S F
authors.initials: SF
authors.lastname: Donnelly
authors.forename: T W
authors.initials: TW
authors.lastname: Brady
authors.forename: G
authors.initials: G
authors.lastname: Anderson
authors.forename: P D
authors.initials: PD
authors.lastname: Mintz
authors.forename: M K
authors.initials: MK
authors.lastname: Moulds
authors.forename: G L
authors.initials: GL
authors.lastname: Daniels
authors.forename: F A
authors.initials: FA
authors.lastname: Spring
authors.forename: N
authors.initials: N
authors.lastname: Molina
authors.forename: E A
authors.initials: EA
authors.lastname: de Asis
authors.forename: E
authors.initials: E
authors.lastname: Olivares
mesh_terms: D000328:Adult; D000906:Antibodies; D016824:Antigens, Human Platelet / Q000276:immunology; D001789:Blood Group Antigens / Q000276:immunology*; D001788:Blood Grouping and Crossmatching; D005192:Family Health; D005260:Female; D005434:Flow Cytometry; D006648:Histocompatibility / Q000276:immunology; D006801:Humans; D015151:Immunoblotting; D007163:Immunosorbent Techniques; D007231:Infant, Newborn; D007519:Isoantigens / Q000097:blood; D010375:Pedigree; D011247:Pregnancy; D006475:Vitamin K Deficiency Bleeding / Q000276:immunology
chemical_list: D000906:Antibodies; D016824:Antigens, Human Platelet; D001789:Blood Group Antigens; D007519:Isoantigens